The extracellular matrix in bronchopulmonary dysplasia: Target and source

Frontiers in Medicine

Volumn 2, Issue DEC, 2015, Pages

  Mižíková, Ivana ^a,b   Morty, Rory E ^a,b  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

Bronchopulmonary dysplasia; Collagen; Elastin; Extracellular matrix; Hyperoxia; Lung development; Mechanical ventilation

Indexed keywords

EID: 85015733146     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2015.00091     Document Type: Review

References (236)

1. Herriges M, Morrisey EE. Lung development: orchestrating the generation and regeneration of a complex organ. Development (2014) 141(3):502-13. doi:10.1242/dev.098186
2. Morrisey EE, Cardoso WV, Lane RH, Rabinovitch M, Abman SH, Ai X, et al. Molecular determinants of lung development. Ann Am Thorac Soc (2013) 10(2):S12-6. doi:10.1513/AnnalsATS.201207-036OT
3. Morrisey EE, Hogan BL. Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell (2010) 18(1):8-23. doi:10.1016/j.devcel.2009.12.010
4. Rawlins EL. The building blocks of mammalian lung development. Dev Dyn (2011) 240(3):463-76. doi:10.1002/dvdy.22482
5. Minoo P, Li C. Cross-talk between transforming growth factor-beta and Wingless/int pathways in lung development and disease. Int J Biochem Cell Biol (2010) 42(6):809-12. doi:10.1016/j.biocel.2010.02.011
6. McCulley D, Wienhold M, Sun X. The pulmonary mesenchyme directs lung development. Curr Opin Genet Dev (2015) 32:98-105. doi:10.1016/j.gde.2015.01.011
7. Volckaert T, De Langhe SP. Wnt and FGF mediated epithelial-mesenchymal crosstalk during lung development. Dev Dyn (2015) 244(3):342-66. doi:10.1002/dvdy.24234
8. Mariani TJ, Reed JJ, Shapiro SD. Expression profiling of the developing mouse lung: insights into the establishment of the extracellular matrix. Am J Respir Cell Mol Biol (2002) 26(5):541-8. doi:10.1165/ajrcmb.26.5.2001-00080c
9. Greenlee KJ, Werb Z, Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev (2007) 87(1):69-98. doi:10.1152/physrev.00022.2006
10. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med (1967) 276(7):357-68. doi:10.1056/NEJM196702162760701
11. Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev (1998) 53(1):81-94. doi:10.1016/S0378-3782(98)00045-0
12. Northway WH Jr. Bronchopulmonary dysplasia: twenty-five years later. Pediatrics (1992) 89(5 Pt 1):969-73
13. Madurga A, Mižíková I, Ruiz-Camp J, Morty RE. Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol (2013) 305(12):L893-905. doi:10.1152/ajplung.00267.2013
14. Jobe AH. The new bronchopulmonary dysplasia. Curr Opin Pediatr (2011) 23(2):167-72. doi:10.1097/MOP.0b013e3283423e6b
15. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med (2007) 357(19):1946-55. doi:10.1056/NEJMra067279
16. Wong PM, Lees AN, Louw J, Lee FY, French N, Gain K, et al. Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J (2008) 32(2):321-8. doi:10.1183/09031936.00127107
17. Hilgendorff A, O'Reilly MA. Bronchopulmonary dysplasia early changes leading to long-term consequences. Front Med (2015) 2:2. doi:10.3389/fmed.2015.00002
18. Baker CD, Abman SH. Impaired pulmonary vascular development in bronchopulmonary dysplasia. Neonatology (2015) 107(4):344-51. doi:10.1159/000381129
19. Bruce MC, Wedig KE, Jentoft N, Martin RJ, Cheng PW, Boat TF, et al. Altered urinary excretion of elastin cross-links in premature infants who develop bronchopulmonary dysplasia. Am Rev Respir Dis (1985) 131(4):568-72
20. Thibeault DW, Mabry SM, Ekekezie II, Truog WE. Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. Pediatrics (2000) 106(6):1452-9. doi:10.1542/peds.106.6.1452
21. Thibeault DW, Mabry SM, Ekekezie II, Zhang X, Truog WE. Collagen scaffolding during development and its deformation with chronic lung disease. Pediatrics (2003) 111(4 Pt 1):766-76. doi:10.1542/peds.111.4.766
22. McGowan SE. Extracellular matrix and the regulation of lung development and repair. FASEB J (1992) 6(11):2895-904
23. Bland RD, Ertsey R, Mokres LM, Xu L, Jacobson BE, Jiang S, et al. Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice. Prelude to defective alveolar septation during lung development? Am J Physiol Lung Cell Mol Physiol (2008) 294(1):L3-14. doi:10.1152/ajplung.00362.2007
24. Bland RD, Xu L, Ertsey R, Rabinovitch M, Albertine KH, Wynn KA, et al. Dysregulation of pulmonary elastin synthesis and assembly in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol (2007) 292(6):L1370-84. doi:10.1152/ajplung.00367.2006
25. Ozbek S, Balasubramanian PG, Chiquet-Ehrismann R, Tucker RP, Adams JC. The evolution of extracellular matrix. Mol Biol Cell (2010) 21(24):4300-5. doi:10.1091/mbc.E10-03-0251
26. Lang MR, Fiaux GW, Gillooly M, Stewart JA, Hulmes DJ, Lamb D. Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax (1994) 49(4):319-26. doi:10.1136/thx.49.4.319
27. Mäki JM, Sormunen R, Lippo S, Kaarteenaho-Wiik R, Soininen R, Myllyharju J. Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. Am J Pathol (2005) 167(4):927-36. doi:10.1016/s0002-9440(10)61183-2
28. Trask TM, Trask BC, Ritty TM, Abrams WR, Rosenbloom J, Mecham RP. Interaction of tropoelastin with the amino-terminal domains of fibrillin-1 and fibrillin-2 suggests a role for the fibrillins in elastic fiber assembly. J Biol Chem (2000) 275(32):24400-6. doi:10.1074/jbc.M003665200
29. Nakamura T, Lozano PR, Ikeda Y, Iwanaga Y, Hinek A, Minamisawa S, et al. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature (2002) 415(6868):171-5. doi:10.1038/415171a
30. Benjamin JT, Gaston DC, Halloran BA, Schnapp LM, Zent R, Prince LS. The role of integrin alpha8beta1 in fetal lung morphogenesis and injury. Dev Biol (2009) 335(2):407-17. doi:10.1016/j.ydbio.2009.09.021
31. Adamson SL. Regulation of breathing at birth. J Dev Physiol (1991) 15(1):45-52
32. Bourbon J, Boucherat O, Chailley-Heu B, Delacourt C. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res (2005) 57(5 Pt 2):38R-46R. doi:10.1203/01.PDR.0000159630.35883.BE
33. Wessells NK. Mammalian lung development: interactions in formation and morphogenesis of tracheal buds. J Exp Zool (1970) 175(4):455-66. doi:10.1002/jez.1401750405
34. Bradley K, McConnell-Breul S, Crystal RG. Lung collagen heterogeneity. Proc Natl Acad Sci U S A (1974) 71(7):2828-32. doi:10.1073/pnas.71.7.2828
35. Bradley KH, McConnell SD, Crystal RG. Lung collagen composition and synthesis. Characterization and changes with age. J Biol Chem (1974) 249(9):2674-83
36. Hance AJ, Bradley K, Crystal RG. Lung collagen heterogeneity. Synthesis of type I and type III collagen by rabbit and human lung cells in culture. J Clin Invest (1976) 57(1):102-11. doi:10.1172/JCI108250
37. Arden MG, Spearman MA, Adamson IY. Degradation of type IV collagen during the development of fetal rat lung. Am J Respir Cell Mol Biol (1993) 9(1):99-105. doi:10.1165/ajrcmb/9.1.99
38. Chen JM, Little CD. Cellular events associated with lung branching morphogenesis including the deposition of collagen type IV. Dev Biol (1987) 120(2):311-21. doi:10.1016/0012-1606(87)90234-X
39. Powell JT, Whitney PL. Postnatal development of rat lung. Changes in lung lectin, elastin, acetylcholinesterase and other enzymes. Biochem J (1980) 188(1):1-8. doi:10.1042/bj1880001
40. Shibahara SU, Davidson JM, Smith K, Crystal RG. Modulation of tropoelastin production and elastin messenger ribonucleic acid activity in developing sheep lung. Biochemistry (1981) 20(23):6577-84. doi:10.1021/bi00526a009
41. Myers B, Dubick M, Last JA, Rucker RB. Elastin synthesis during perinatal lung development in the rat. Biochim Biophys Acta (1983) 761(1):17-22. doi:10.1016/0304-4165(83)90357-4
42. Das RM. The effect of beta-aminopropionitrile on lung development in the rat. Am J Pathol (1980) 101(3):711-22
43. Margraf LR, Tomashefski JF Jr, Bruce MC, Dahms BB. Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis (1991) 143(2):391-400. doi:10.1164/ajrccm/143.2.391
44. Nakamura Y, Fukuda S, Hashimoto T. Pulmonary elastic fibers in normal human development and in pathological conditions. Pediatr Pathol (1990) 10(5):689-706. doi:10.3109/15513819009064705
45. Wakafuji S. Pathological and histometrical studies on alveolar ducts and respiratory bronchioli. Kobe J Med Sci (1985) 31(5):203-20
46. Thibeault DW, Truog WE, Ekekezie II. Acinar arterial changes with chronic lung disease of prematurity in the surfactant era. Pediatr Pulmonol (2003) 36(6):482-9. doi:10.1002/ppul.10349
47. Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci (2010) 123(Pt 24):4195-200. doi:10.1242/jcs.023820
48. Kaarteenaho-Wiik R, Paakko P, Herva R, Risteli J, Soini Y. Type I and III collagen protein precursors and mRNA in the developing human lung. J Pathol (2004) 203(1):567-74. doi:10.1002/path.1547
49. Lohler J, Timpl R, Jaenisch R. Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death. Cell (1984) 38(2):597-607. doi:10.1016/0092-8674(84)90514-2
50. Kratochwil K, Dziadek M, Lohler J, Harbers K, Jaenisch R. Normal epithelial branching morphogenesis in the absence of collagen I. Dev Biol (1986) 117(2):596-606. doi:10.1016/0012-1606(86)90328-3
51. Han W, Guo C, Liu Q, Yu B, Liu Z, Yang J, et al. Aberrant elastin remodeling in the lungs of O(2)-exposed newborn mice; primarily results from perturbed interaction between integrins and elastin. Cell Tissue Res (2015) 359(2):589-603. doi:10.1007/s00441-014-2035-1
52. Olsen KC, Sapinoro RE, Kottmann RM, Kulkarni AA, Iismaa SE, Johnson GV, et al. Transglutaminase 2 and its role in pulmonary fibrosis. Am J Respir Crit Care Med (2011) 184(6):699-707. doi:10.1164/rccm.201101-0013OC
53. Nakamura T, Liu M, Mourgeon E, Slutsky A, Post M. Mechanical strain and dexamethasone selectively increase surfactant protein C and tropoelastin gene expression. Am J Physiol Lung Cell Mol Physiol (2000) 278(5):L974-80
54. Fattman CL, Schaefer LM, Oury TD. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med (2003) 35(3):236-56. doi:10.1016/S0891-5849(03)00275-2
55. Poonyagariyagorn HK, Metzger S, Dikeman D, Mercado AL, Malinina A, Calvi C, et al. Superoxide dismutase 3 dysregulation in a murine model of neonatal lung injury. Am J Respir Cell Mol Biol (2014) 51(3):380-90. doi:10.1165/rcmb.2013-0043OC
56. Roth-Kleiner M, Berger TM, Gremlich S, Tschanz SA, Mund SI, Post M, et al. Neonatal steroids induce a down-regulation of tenascin-C and elastin and cause a deceleration of the first phase and an acceleration of the second phase of lung alveolarization. Histochem Cell Biol (2014) 141(1):75-84. doi:10.1007/s00418-013-1132-7
57. Quondamatteo F, Reinhardt DP, Charbonneau NL, Pophal G, Sakai LY, Herken R. Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. Matrix Biol (2002) 21(8):637-46. doi:10.1016/S0945-053X(02)00100-2
58. Vehvilainen P, Hyytiainen M, Keski-Oja J. Matrix association of latent TGF-beta binding protein-2 (LTBP-2) is dependent on fibrillin-1. J Cell Physiol (2009) 221(3):586-93. doi:10.1002/jcp.21888
59. Lima BL, Santos EJ, Fernandes GR, Merkel C, Mello MR, Gomes JP, et al. A new mouse model for Marfan syndrome presents phenotypic variability associated with the genetic background and overall levels of Fbn1 expression. PLoS One (2010) 5(11):e14136. doi:10.1371/journal.pone.0014136
60. Sinkin RA, Roberts M, LoMonaco MB, Sanders RJ, Metlay LA. Fibronectin expression in bronchopulmonary dysplasia. Pediatr Dev Pathol (1998) 1(6):494-502. doi:10.1007/s100249900068
61. Kobayashi T, Kim H, Liu X, Sugiura H, Kohyama T, Fang Q, et al. Matrix metalloproteinase-9 activates TGF-beta and stimulates fibroblast contraction of collagen gels. Am J Physiol Lung Cell Mol Physiol (2014) 306(11):L1006-15. doi:10.1152/ajplung.00015.2014
62. Rennard SI, Crystal RG. Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. J Clin Invest (1982) 69(1):113-22. doi:10.1172/JCI110421
63. Kuang PP, Goldstein RH, Liu Y, Rishikof DC, Jean JC, Joyce-Brady M. Coordinate expression of fibulin-5/DANCE and elastin during lung injury repair. Am J Physiol Lung Cell Mol Physiol (2003) 285(5):L1147-52. doi:10.1152/ajplung.00098.2003
64. Liu X, Zhao Y, Gao J, Pawlyk B, Starcher B, Spencer JA, et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet (2004) 36(2):178-82. doi:10.1038/ng1297
65. Thompson SM, Connell MG, van Kuppevelt TH, Xu R, Turnbull JE, Losty PD, et al. Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation? BMC Dev Biol (2011) 11:38. doi:10.1186/1471-213X-11-38
66. Yue X, Li X, Nguyen HT, Chin DR, Sullivan DE, Lasky JA. Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo. J Biol Chem (2008) 283(29):20397-407. doi:10.1074/jbc.M802850200
67. Sheppard D. Functions of pulmonary epithelial integrins: from development to disease. Physiol Rev (2003) 83(3):673-86. doi:10.1152/physrev.00033.2002
68. Coraux C, Meneguzzi G, Rousselle P, Puchelle E, Gaillard D. Distribution of laminin 5, integrin receptors, and branching morphogenesis during human fetal lung development. Dev Dyn (2002) 225(2):176-85. doi:10.1002/dvdy.10147
69. Caniggia I, Liu J, Han R, Wang J, Tanswell AK, Laurie G, et al. Identification of receptors binding fibronectin and laminin on fetal rat lung cells. Am J Physiol (1996) 270(3 Pt 1):L459-68
70. Wu JE, Santoro SA. Differential expression of integrin alpha subunits supports distinct roles during lung branching morphogenesis. Dev Dyn (1996) 206(2):169-81. doi:10.1002/(SICI)1097-0177(199606)206:2<169::AID-AJA6>3.0.CO;2-G
71. Damjanovich L, Albelda SM, Mette SA, Buck CA. Distribution of integrin cell adhesion receptors in normal and malignant lung tissue. Am J Respir Cell Mol Biol (1992) 6(2):197-206. doi:10.1165/ajrcmb/6.2.197
72. Kumarasamy A, Schmitt I, Nave AH, Reiss I, van der Horst I, Dony E, et al. Lysyl oxidase activity is dysregulated during impaired alveolarization of mouse and human lungs. Am J Respir Crit Care Med (2009) 180(12):1239-52. doi:10.1164/rccm.200902-0215OC
73. Nave AH, Mizikova I, Niess G, Steenbock H, Reichenberger F, Talavera ML, et al. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol (2014) 34(7):1446-58. doi:10.1161/ATVBAHA.114.303534
74. Fukuda Y, Ishizaki M, Okada Y, Seiki M, Yamanaka N. Matrix metalloproteinases and tissue inhibitor of metalloproteinase-2 in fetal rabbit lung. Am J Physiol Lung Cell Mol Physiol (2000) 279(3):L555-61
75. Boucherat O, Bourbon JR, Barlier-Mur AM, Chailley-Heu B, D'Ortho MP, Delacourt C. Differential expression of matrix metalloproteinases and inhibitors in developing rat lung mesenchymal and epithelial cells. Pediatr Res (2007) 62(1):20-5. doi:10.1203/PDR.0b013e3180686cc5
76. Atkinson JJ, Holmbeck K, Yamada S, Birkedal-Hansen H, Parks WC, Senior RM. Membrane-type 1 matrix metalloproteinase is required for normal alveolar development. Dev Dyn (2005) 232(4):1079-90. doi:10.1002/dvdy.20267
77. Pardo A, Barrios R, Maldonado V, Melendez J, Perez J, Ruiz V, et al. Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications. Am J Pathol (1998) 153(3):833-44. doi:10.1016/S0002-9440(10)65625-8
78. Buckley S, Warburton D. Dynamics of metalloproteinase-2 and-9, TGF-beta, and uPA activities during normoxic vs. hyperoxic alveolarization. Am J Physiol Lung Cell Mol Physiol (2002) 283(4):L747-54. doi:10.1152/ajplung.00415.2001
79. Dik WA, van Kaam AH, Dekker T, Naber BA, Janssen DJ, Kroon AA, et al. Early increased levels of matrix metalloproteinase-9 in neonates recovering from respiratory distress syndrome. Biol Neonate (2006) 89(1):6-14. doi:10.1159/000088193
80. Witsch TJ, Turowski P, Sakkas E, Niess G, Becker S, Herold S, et al. Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol (2014) 306(3):L246-59. doi:10.1152/ajplung.00109.2013
81. Paakko P, Kaarteenaho-Wiik R, Pollanen R, Soini Y. Tenascin mRNA expression at the foci of recent injury in usual interstitial pneumonia. Am J Respir Crit Care Med (2000) 161(3 Pt 1):967-72. doi:10.1164/ajrccm.161.3.9809115
82. Estany S, Vicens-Zygmunt V, Llatjos R, Montes A, Penin R, Escobar I, et al. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFbeta1. BMC Pulm Med (2014) 14:120. doi:10.1186/1471-2466-14-120
83. Kaarteenaho-Wiik R, Kinnula VL, Herva R, Soini Y, Pollanen R, Paakko P. Tenascin-C is highly expressed in respiratory distress syndrome and bronchopulmonary dysplasia. J Histochem Cytochem (2002) 50(3):423-31. doi:10.1177/002215540205000313
84. Kaarteenaho-Wiik R, Kinnula V, Herva R, Paakko P, Pollanen R, Soini Y. Distribution and mRNA expression of tenascin-C in developing human lung. Am J Respir Cell Mol Biol (2001) 25(3):341-6. doi:10.1165/ajrcmb.25.3.4460
85. Witsch TJ, Niess G, Sakkas E, Likhoshvay T, Becker S, Herold S, et al. Transglutaminase 2: a new player in bronchopulmonary dysplasia? Eur Respir J (2014) 44(1):109-21. doi:10.1183/09031936.00075713
86. Oh K, Park HB, Byoun OJ, Shin DM, Jeong EM, Kim YW, et al. Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice. J Exp Med (2011) 208(8):1707-19. doi:10.1084/jem.20101457
87. Oh K, Seo MW, Lee GY, Byoun OJ, Kang HR, Cho SH, et al. Airway epithelial cells initiate the allergen response through transglutaminase 2 by inducing IL-33 expression and a subsequent Th2 response. Respir Res (2013) 14:35. doi:10.1186/1465-9921-14-35
88. Kononov S, Brewer K, Sakai H, Cavalcante FS, Sabayanagam CR, Ingenito EP, et al. Roles of mechanical forces and collagen failure in the development of elastase-induced emphysema. Am J Respir Crit Care Med (2001) 164(10 Pt 1):1920-6. doi:10.1164/ajrccm.164.10.2101083
89. Mižíková I, Ruiz-Camp J, Steenbock H, Madurga A, Vadász I, Herold S, et al. Collagen and elastin cross-linking is altered during aberrant late lung development associated with hyperoxia. Am J Physiol Lung Cell Mol Physiol (2015) 308(11):L1145-58. doi:10.1152/ajplung.00039.2015
90. Shoemaker CT, Reiser KM, Goetzman BW, Last JA. Elevated ratios of type I/III collagen in the lungs of chronically ventilated neonates with respiratory distress. Pediatr Res (1984) 18(11):1176-80. doi:10.1203/00006450-198411000-00025
91. Ohki Y, Kato M, Kimura H, Nako Y, Tokuyama K, Morikawa A. Elevated type IV collagen in bronchoalveolar lavage fluid from infants with bronchopulmonary dysplasia. Biol Neonate (2001) 79(1):34-8. doi:10.1159/000047063
92. Moore AM, Buch S, Han RN, Freeman BA, Post M, Tanswell AK. Altered expression of type I collagen, TGF-beta 1, and related genes in rat lung exposed to 85% O2. Am J Physiol (1995) 268(1 Pt 1):L78-84
93. Chetty A, Cao GJ, Severgnini M, Simon A, Warburton R, Nielsen HC. Role of matrix metalloprotease-9 in hyperoxic injury in developing lung. Am J Physiol Lung Cell Mol Physiol (2008) 295(4):L584-92. doi:10.1152/ajplung.00441.2007
94. Mammoto T, Jiang E, Jiang A, Mammoto A. Extracellular matrix structure and tissue stiffness control postnatal lung development through the lipoprotein receptor-related protein 5/Tie2 signaling system. Am J Respir Cell Mol Biol (2013) 49(6):1009-18. doi:10.1165/rcmb.2013-0147OC
95. Alejandre-Alcázar MA, Kwapiszewska G, Reiss I, Amarie OV, Marsh LM, Sevilla-Perez J, et al. Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol (2007) 292(2):L537-49. doi:10.1152/ajplung.00050.2006
96. Hirakawa H, Pierce RA, Bingol-Karakoc G, Karaaslan C, Weng M, Shi GP, et al. Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury. Am J Respir Crit Care Med (2007) 176(8):778-85. doi:10.1164/rccm.200704-519OC
97. Bozyk PD, Bentley JK, Popova AP, Anyanwu AC, Linn MD, Goldsmith AM, et al. Neonatal periostin knockout mice are protected from hyperoxia-induced alveolar simplication. PLoS One (2012) 7(2):e31336. doi:10.1371/journal.pone.0031336
98. Masood A, Yi M, Belcastro R, Li J, Lopez L, Kantores C, et al. Neutrophil elastase-induced elastin degradation mediates macrophage influx and lung injury in 60% O2-exposed neonatal rats. Am J Physiol Lung Cell Mol Physiol (2015) 309(1):L53-62. doi:10.1152/ajplung.00298.2014
99. Hilgendorff A, Parai K, Ertsey R, Navarro E, Jain N, Carandang F, et al. Lung matrix and vascular remodeling in mechanically ventilated elastin haploinsufficient newborn mice. Am J Physiol Lung Cell Mol Physiol (2015) 308(5):L464-78. doi:10.1152/ajplung.00278.2014
100. Hilgendorff A, Parai K, Ertsey R, Jain N, Navarro EF, Peterson JL, et al. Inhibiting lung elastase activity enables lung growth in mechanically ventilated newborn mice. Am J Respir Crit Care Med (2011) 184(5):537-46. doi:10.1164/rccm.201012-2010OC
101. Hilgendorff A, Parai K, Ertsey R, Juliana Rey-Parra G, Thebaud B, Tamosiuniene R. Neonatal mice genetically modified to express the elastase inhibitor elafin are protected against the adverse effects of mechanical ventilation on lung growth. Am J Physiol Lung Cell Mol Physiol (2012) 303(3):L215-27. doi:10.1152/ajplung.00405.2011
102. Pierce RA, Albertine KH, Starcher BC, Bohnsack JF, Carlton DP, Bland RD. Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. Am J Physiol (1997) 272(3 Pt 1):L452-60
103. Kroon AA, Wang J, Post M. Alterations in expression of elastogenic and angiogenic genes by different conditions of mechanical ventilation in newborn rat lung. Am J Physiol Lung Cell Mol Physiol (2015) 308(7):L639-49. doi:10.1152/ajplung.00293.2014
104. Watts CL, Fanaroff AA, Bruce MC. Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia. J Pediatr (1992) 120(4 Pt 1):614-20. doi:10.1016/S0022-3476(05)82492-8
105. Zhang X, Xu J, Wang J, Gortner L, Zhang S, Wei X, et al. Reduction of microRNA-206 contributes to the development of bronchopulmonary dysplasia through up-regulation of fibronectin 1. PLoS One (2013) 8(9):e74750. doi:10.1371/journal.pone.0074750
106. Sinkin RA, LoMonaco MB, Finkelstein JN, Watkins RH, Cox C, Horowitz S. Increased fibronectin mRNA in alveolar macrophages following in vivo hyperoxia. Am J Respir Cell Mol Biol (1992) 7(5):548-55. doi:10.1165/ajrcmb/7.5.548
107. Tambunting F, Beharry KD, Hartleroad J, Waltzman J, Stavitsky Y, Modanlou HD. Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia. Pediatr Pulmonol (2005) 39(1):5-14. doi:10.1002/ppul.20135
108. Hadchouel A, Decobert F, Franco-Montoya ML, Halphen I, Jarreau PH, Boucherat O, et al. Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development. PLoS One (2008) 3(9):e3188. doi:10.1371/journal.pone.0003188
109. Danan C, Jarreau PH, Franco ML, Dassieu G, Grillon C, Abd Alsamad I, et al. Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol (2002) 283(5):L1086-93. doi:10.1152/ajplung.00066.2002
110. Hosford GE, Fang X, Olson DM. Hyperoxia decreases matrix metalloproteinase-9 and increases tissue inhibitor of matrix metalloproteinase-1 protein in the newborn rat lung: association with arrested alveolarization. Pediatr Res (2004) 56(1):26-34. doi:10.1203/01.PDR.0000130658.45564.1F
111. Cederqvist K, Sorsa T, Tervahartiala T, Maisi P, Reunanen K, Lassus P, et al. Matrix metalloproteinases-2,-8, and-9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics (2001) 108(3):686-92. doi:10.1542/peds.108.3.686
112. Sweet DG, McMahon KJ, Curley AE, O'Connor CM, Halliday HL. Type I collagenases in bronchoalveolar lavage fluid from preterm babies at risk of developing chronic lung disease. Arch Dis Child Fetal Neonatal Ed (2001) 84(3):F168-71. doi:10.1136/fn.84.3.F168
113. Ekekezie II, Thibeault DW, Simon SD, Norberg M, Merrill JD, Ballard RA, et al. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics (2004) 113(6):1709-14. doi:10.1542/peds.113.6.1709
114. Sweet DG, Curley AE, Chesshyre E, Pizzotti J, Wilbourn MS, Halliday HL, et al. The role of matrix metalloproteinases-9 and-2 in development of neonatal chronic lung disease. Acta Paediatr (2004) 93(6):791-6. doi:10.1111/j.1651-2227.2004.tb03020.x
115. Kotecha S, Wangoo A, Silverman M, Shaw RJ. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr (1996) 128(4):464-9. doi:10.1016/S0022-3476(96)70355-4
116. McAnulty RJ, Campa JS, Cambrey AD, Laurent GJ. The effect of transforming growth factor beta on rates of procollagen synthesis and degradation in vitro. Biochim Biophys Acta (1991) 1091(2):231-5. doi:10.1016/0167-4889(91)90066-7
117. Nakanishi H, Sugiura T, Streisand JB, Lonning SM, Roberts JD Jr. TGF-beta-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung. Am J Physiol Lung Cell Mol Physiol (2007) 293(1):L151-61. doi:10.1152/ajplung.00389.2006
118. Vicencio AG, Lee CG, Cho SJ, Eickelberg O, Chuu Y, Haddad GG, et al. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia? Am J Respir Cell Mol Biol (2004) 31(6):650-6. doi:10.1165/rcmb.2004-0092OC
119. Tarantal AF, Chen H, Shi TT, Lu CH, Fang AB, Buckley S, et al. Overexpression of transforming growth factor-beta1 in fetal monkey lung results in prenatal pulmonary fibrosis. Eur Respir J (2010) 36(4):907-14. doi:10.1183/09031936.00011810
120. Pierce RA, Mariani TJ, Senior RM. Elastin in lung development and disease. Ciba Found Symp (1995) 192:199-212
121. Burri PH, Weibel ER. Ultrastructure and morphometry of the developing lung. In: Hodson WA, editor. Development of the Lung, Part 1: Structural Development. New York, NY: Marcel Decker (1977). p. 215-68
122. Emery JL. The post natal development of the human lung and its implications for lung pathology. Respiration (1970) 27(Suppl):41-50. doi:10.1159/000192718
123. Noguchi A, Reddy R, Kursar JD, Parks WC, Mecham RP. Smooth muscle isoactin and elastin in fetal bovine lung. Exp Lung Res (1989) 15(4):537-52. doi:10.3109/01902148909069617
124. Wendel DP, Taylor DG, Albertine KH, Keating MT, Li DY. Impaired distal airway development in mice lacking elastin. Am J Respir Cell Mol Biol (2000) 23(3):320-6. doi:10.1165/ajrcmb.23.3.3906
125. Shifren A, Durmowicz AG, Knutsen RH, Hirano E, Mecham RP. Elastin protein levels are a vital modifier affecting normal lung development and susceptibility to emphysema. Am J Physiol Lung Cell Mol Physiol (2007) 292(3):L778-87. doi:10.1152/ajplung.00352.2006
126. Bruce MC, Schuyler M, Martin RJ, Starcher BC, Tomashefski JF Jr, Wedig KE. Risk factors for the degradation of lung elastic fibers in the ventilated neonate. Implications for impaired lung development in bronchopulmonary dysplasia. Am Rev Respir Dis (1992) 146(1):204-12. doi:10.1164/ajrccm/146.1.204
127. Mascaretti RS, Mataloun MM, Dolhnikoff M, Rebello CM. Lung morphometry, collagen and elastin content: changes after hyperoxic exposure in preterm rabbits. Clinics (Sao Paulo) (2009) 64(11):1099-104. doi:10.1590/S1807-59322009001100010
128. Pierce RA, Joyce B, Officer S, Heintz C, Moore C, McCurnin D, et al. Retinoids increase lung elastin expression but fail to alter morphology or angiogenesis genes in premature ventilated baboons. Pediatr Res (2007) 61(6):703-9. doi:10.1203/pdr.0b013e318053661d
129. Albertine KH, Jones GP, Starcher BC, Bohnsack JF, Davis PL, Cho SC, et al. Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med (1999) 159(3):945-58. doi:10.1164/ajrccm.159.3.9804027
130. McGowan SE, McNamer R. Transforming growth factor-beta increases elastin production by neonatal rat lung fibroblasts. Am J Respir Cell Mol Biol (1990) 3(4):369-76. doi:10.1165/ajrcmb/3.4.369
131. McGowan SE. Paracrine cellular and extracellular matrix interactions with mesenchymal progenitors during pulmonary alveolar septation. Birth Defects Res A Clin Mol Teratol (2014) 100(3):227-39. doi:10.1002/bdra.23230
132. Noguchi A, Nelson T. IGF-I stimulates tropoelastin synthesis in neonatal rat pulmonary fibroblasts. Pediatr Res (1991) 30(3):248-51. doi:10.1203/00006450-199109000-00009
133. Sproul EP, Argraves WS. A cytokine axis regulates elastin formation and degradation. Matrix Biol (2013) 32(2):86-94. doi:10.1016/j.matbio.2012.11.004
134. McGowan SE, Jackson SK, Olson PJ, Parekh T, Gold LI. Exogenous and endogenous transforming growth factors-beta influence elastin gene expression in cultured lung fibroblasts. Am J Respir Cell Mol Biol (1997) 17(1):25-35. doi:10.1165/ajrcmb.17.1.2686
135. Li J, Masood A, Yi M, Lau M, Belcastro R, Ivanovska J, et al. The IGF-I/IGF-R1 pathway regulates postnatal lung growth and is a nonspecific regulator of alveologenesis in the neonatal rat. Am J Physiol Lung Cell Mol Physiol (2013) 304(9):L626-37. doi:10.1152/ajplung.00198.2012
136. Chetty A, Andersson S, Lassus P, Nielsen HC. Insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) expression in human lung in RDS and BPD. Pediatr Pulmonol (2004) 37(2):128-36. doi:10.1002/ppul.10415
137. Popova AP, Bentley JK, Cui TX, Richardson MN, Linn MJ, Lei J, et al. Reduced platelet-derived growth factor receptor expression is a primary feature of human bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol (2014) 307(3):L231-9. doi:10.1152/ajplung.00342.2013
138. Dubick MA, Rucker RB, Cross CE, Last JA. Elastin metabolism in rodent lung. Biochim Biophys Acta (1981) 672(3):303-6. doi:10.1016/0304-4165(81)90297-X
139. Zhang P, Huang A, Ferruzzi J, Mecham RP, Starcher BC, Tellides G, et al. Inhibition of microRNA-29 enhances elastin levels in cells haploinsufficient for elastin and in bioengineered vessels-brief report. Arterioscler Thromb Vasc Biol (2012) 32(3):756-9. doi:10.1161/ATVBAHA.111.238113
140. Leimeister C, Steidl C, Schumacher N, Erhard S, Gessler M. Developmental expression and biochemical characterization of Emu family members. Dev Biol (2002) 249(2):204-18. doi:10.1006/dbio.2002.0764
141. Hirai M, Horiguchi M, Ohbayashi T, Kita T, Chien KR, Nakamura T. Latent TGF-beta-binding protein 2 binds to DANCE/fibulin-5 and regulates elastic fiber assembly. EMBO J (2007) 26(14):3283-95. doi:10.1038/sj.emboj.7601768
142. Mecham RP, Gibson MA. The microfibril-associated glycoproteins (MAGPs) and the microfibrillar niche. Matrix Biol (2015) 47:13-33. doi:10.1016/j.matbio.2015.05.003
143. Burgess JK, Weckmann M. Matrikines and the lungs. Pharmacol Ther (2012) 134(3):317-37. doi:10.1016/j.pharmthera.2012.02.002
144. Morty RE. Targeting elastase in bronchopulmonary dysplasia. Am J Respir Crit Care Med (2011) 184(5):496-7. doi:10.1164/rccm.201105-0930ED
145. Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres. J Cell Sci (2002) 115(Pt 14):2817-28
146. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet (2003) 33(3):407-11. doi:10.1038/ng1116
147. Robbesom AA, Koenders MM, Smits NC, Hafmans T, Versteeg EM, Bulten J, et al. Aberrant fibrillin-1 expression in early emphysematous human lung: a proposed predisposition for emphysema. Mod Pathol (2008) 21(3):297-307. doi:10.1038/modpathol.3801004
148. Kida K, Thurlbeck WM. Lack of recovery of lung structure and function after the administration of beta-amino-propionitrile in the postnatal period. Am Rev Respir Dis (1980) 122(3):467-75
149. Kida K, Thurlbeck WM. The effects of beta-aminopropionitrile on the growing rat lung. Am J Pathol (1980) 101(3):693-710
150. Roth-Kleiner M, Hirsch E, Schittny JC. Fetal lungs of tenascin-C-deficient mice grow well, but branch poorly in organ culture. Am J Respir Cell Mol Biol (2004) 30(3):360-6. doi:10.1165/rcmb.2002-0266OC
151. Mosher DF. Physiology of fibronectin. Annu Rev Med (1984) 35:561-75. doi:10.1146/annurev.me.35.020184.003021
152. Dean DC. Expression of the fibronectin gene. Am J Respir Cell Mol Biol (1989) 1(1):5-10. doi:10.1165/ajrcmb/1.1.5
153. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development (1993) 119(4):1079-91
154. Gerdes JS, Yoder MC, Douglas SD, Paul M, Harris MC, Polin RA. Tracheal lavage and plasma fibronectin: relationship to respiratory distress syndrome and development of bronchopulmonary dysplasia. J Pediatr (1986) 108(4):601-6. doi:10.1016/S0022-3476(86)80847-2
155. Dyke MP, Forsyth KD. Plasma fibronectin levels in extremely preterm infants in the first 8 weeks of life. J Paediatr Child Health (1994) 30(1):36-9. doi:10.1111/j.1440-1754.1994.tb00563.x
156. Timpl R, Sasaki T, Kostka G, Chu ML. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol (2003) 4(6):479-89. doi:10.1038/nrm1130
157. Yanagisawa H, Davis EC, Starcher BC, Ouchi T, Yanagisawa M, Richardson JA, et al. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature (2002) 415(6868):168-71. doi:10.1038/415168a
158. Schiemann WP, Blobe GC, Kalume DE, Pandey A, Lodish HF. Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J Biol Chem (2002) 277(30):27367-77. doi:10.1074/jbc.M200148200
159. Lee YH, Albig AR, Regner M, Schiemann BJ, Schiemann WP. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism. Carcinogenesis (2008) 29(12):2243-51. doi:10.1093/carcin/bgn199
160. Nguyen AD, Itoh S, Jeney V, Yanagisawa H, Fujimoto M, Ushio-Fukai M, et al. Fibulin-5 is a novel binding protein for extracellular superoxide dismutase. Circ Res (2004) 95(11):1067-74. doi:10.1161/01.RES.0000149568.85071.FB
161. Colombatti A, Doliana R, Bot S, Canton A, Mongiat M, Mungiguerra G, et al. The EMILIN protein family. Matrix Biol (2000) 19(4):289-301. doi:10.1016/S0945-053X(00)00074-3
162. Zanetti M, Braghetta P, Sabatelli P, Mura I, Doliana R, Colombatti A, et al. EMILIN-1 deficiency induces elastogenesis and vascular cell defects. Mol Cell Biol (2004) 24(2):638-50. doi:10.1128/MCB.24.2.638-650.2004
163. Liu S, Parameswaran H, Young SM, Varisco BM. JNK suppresses pulmonary fibroblast elastogenesis during alveolar development. Respir Res (2014) 15:34. doi:10.1186/1465-9921-15-34
164. Robertson IB, Horiguchi M, Zilberberg L, Dabovic B, Hadjiolova K, Rifkin DB. Latent TGF-beta-binding proteins. Matrix Biol (2015) 47:44-53. doi:10.1016/j.matbio.2015.05.005
165. Todorovic V, Frendewey D, Gutstein DE, Chen Y, Freyer L, Finnegan E, et al. Long form of latent TGF-beta binding protein 1 (Ltbp1L) is essential for cardiac outflow tract septation and remodeling. Development (2007) 134(20):3723-32. doi:10.1242/dev.008599
166. Dabovic B, Chen Y, Choi J, Davis EC, Sakai LY, Todorovic V, et al. Control of lung development by latent TGF-beta binding proteins. J Cell Physiol (2011) 226(6):1499-509. doi:10.1002/jcp.22479
167. Dabovic B, Robertson IB, Zilberberg L, Vassallo M, Davis EC, Rifkin DB. Function of latent TGFbeta binding protein 4 and fibulin 5 in elastogenesis and lung development. J Cell Physiol (2015) 230(1):226-36. doi:10.1002/jcp.24704
168. Dabovic B, Chen Y, Choi J, Vassallo M, Dietz HC, Ramirez F, et al. Dual functions for LTBP in lung development: LTBP-4 independently modulates elastogenesis and TGF-beta activity. J Cell Physiol (2009) 219(1):14-22. doi:10.1002/jcp.21643
169. Shipley JM, Mecham RP, Maus E, Bonadio J, Rosenbloom J, McCarthy RT, et al. Developmental expression of latent transforming growth factor beta binding protein 2 and its requirement early in mouse development. Mol Cell Biol (2000) 20(13):4879-87. doi:10.1128/MCB.20.13.4879-4887.2000
170. Thompson SM, Jesudason EC, Turnbull JE, Fernig DG. Heparan sulfate in lung morphogenesis: the elephant in the room. Birth Defects Res C Embryo Today (2010) 90(1):32-44. doi:10.1002/bdrc.20169
171. Smits NC, Shworak NW, Dekhuijzen PN, van Kuppevelt TH. Heparan sulfates in the lung: structure, diversity, and role in pulmonary emphysema. Anat Rec (Hoboken) (2010) 293(6):955-67. doi:10.1002/ar.20895
172. Becchetti E, Evangelisti R, Stabellini G, Pagliarini A, del Borrello E, Calastrini C, et al. Developmental heterogeneity of mesenchymal glycosaminoglycans (GAG) distribution in chick embryo lung anlagen. Am J Anat (1988) 181(1):33-42. doi:10.1002/aja.1001810105
173. Brauker JH, Trautman MS, Bernfield M. Syndecan, a cell surface proteoglycan, exhibits a molecular polymorphism during lung development. Dev Biol (1991) 147(2):285-92. doi:10.1016/0012-1606(91)90286-C
174. Caniggia I, Tanswell K, Post M. Temporal and spatial differences in glycosaminoglycan synthesis by fetal lung fibroblasts. Exp Cell Res (1992) 202(2):252-8. doi:10.1016/0014-4827(92)90072-G
175. Vaccaro CA, Brody JS. Ultrastructural localization and characterization of proteoglycans in the pulmonary alveolus. Am Rev Respir Dis (1979) 120(4):901-10
176. Jaskoll TF, Slavkin HC. Ultrastructural and immunofluorescence studies of basal-lamina alterations during mouse-lung morphogenesis. Differentiation (1984) 28(1):36-48. doi:10.1111/j.1432-0436.1984.tb00264.x
177. Izvolsky KI, Shoykhet D, Yang Y, Yu Q, Nugent MA, Cardoso WV. Heparan sulfate-FGF10 interactions during lung morphogenesis. Dev Biol (2003) 258(1):185-200. doi:10.1016/S0012-1606(03)00114-3
178. Calvitti M, Baroni T, Calastrini C, Lilli C, Caramelli E, Becchetti E, et al. Bronchial branching correlates with specific glycosidase activity, extracellular glycosaminoglycan accumulation, TGF beta(2), and IL-1 localization during chick embryo lung development. J Histochem Cytochem (2004) 52(3):325-34. doi:10.1177/002215540405200303
179. Hu Z, Wang C, Xiao Y, Sheng N, Chen Y, Xu Y, et al. NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development. J Cell Sci (2009) 122(Pt 8):1145-54. doi:10.1242/jcs.034736
180. Fan G, Xiao L, Cheng L, Wang X, Sun B, Hu G. Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett (2000) 467(1):7-11. doi:10.1016/S0014-5793(00)01111-X
181. Li JP, Gong F, Hagner-McWhirter A, Forsberg E, Abrink M, Kisilevsky R, et al. Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem (2003) 278(31):28363-6. doi:10.1074/jbc.C300219200
182. Habuchi H, Nagai N, Sugaya N, Atsumi F, Stevens RL, Kimata K. Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality. J Biol Chem (2007) 282(21):15578-88. doi:10.1074/jbc.M607434200
183. Lum DH, Tan J, Rosen SD, Werb Z. Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2. Mol Cell Biol (2007) 27(2):678-88. doi:10.1128/MCB.01279-06
184. Cano-Gauci DF, Song HH, Yang H, McKerlie C, Choo B, Shi W, et al. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J Cell Biol (1999) 146(1):255-64. doi:10.1083/jcb.146.999.255
185. Thompson SM, Connell MG, Fernig DG, Ten Dam GB, van Kuppevelt TH, Turnbull JE, et al. Novel 'phage display antibodies identify distinct heparan sulfate domains in developing mammalian lung. Pediatr Surg Int (2007) 23(5):411-7. doi:10.1007/s00383-006-1864-8
186. Shannon JM, McCormick-Shannon K, Burhans MS, Shangguan X, Srivastava K, Hyatt BA. Chondroitin sulfate proteoglycans are required for lung growth and morphogenesis in vitro. Am J Physiol Lung Cell Mol Physiol (2003) 285(6):L1323-36. doi:10.1152/ajplung.00226.2003
187. Underhill CB, Nguyen HA, Shizari M, Culty M. CD44 positive macrophages take up hyaluronan during lung development. Dev Biol (1993) 155(2):324-36. doi:10.1006/dbio.1993.1032
188. Coraux C, Delplanque A, Hinnrasky J, Peault B, Puchelle E, Gaillard D. Distribution of integrins during human fetal lung development. J Histochem Cytochem (1998) 46(7):803-10. doi:10.1177/002215549804600703
189. Roman J. Fibronectin and fibronectin receptors in lung development. Exp Lung Res (1997) 23(2):147-59. doi:10.3109/01902149709074027
190. Fukai T, Folz RJ, Landmesser U, Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res (2002) 55(2):239-49. doi:10.1016/S0008-6363(02)00328-0
191. Oury TD, Chang LY, Marklund SL, Day BJ, Crapo JD. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab Invest (1994) 70(6):889-98
192. Oury TD, Crapo JD, Valnickova Z, Enghild JJ. Human extracellular superoxide dismutase is a tetramer composed of two disulphide-linked dimers: a simplified, high-yield purification of extracellular superoxide dismutase. Biochem J (1996) 317(Pt 1):51-7. doi:10.1042/bj3170051
193. Petersen SV, Oury TD, Ostergaard L, Valnickova Z, Wegrzyn J, Thogersen IB, et al. Extracellular superoxide dismutase (EC-SOD) binds to type i collagen and protects against oxidative fragmentation. J Biol Chem (2004) 279(14):13705-10. doi:10.1074/jbc.M310217200
194. Hayashi A, Ryu A, Suzuki T, Kawada A, Tajima S. In vitro degradation of tropoelastin by reactive oxygen species. Arch Dermatol Res (1998) 290(9):497-500. doi:10.1007/s004030050342
195. Ryu A, Naru E, Arakane K, Masunaga T, Shinmoto K, Nagano T, et al. Cross-linking of collagen by singlet oxygen generated with UV-A. Chem Pharm Bull (Tokyo) (1997) 45(8):1243-7. doi:10.1248/cpb.45.1243
196. Ahmed MN, Suliman HB, Folz RJ, Nozik-Grayck E, Golson ML, Mason SN, et al. Extracellular superoxide dismutase protects lung development in hyperoxia-exposed newborn mice. Am J Respir Crit Care Med (2003) 167(3):400-5. doi:10.1164/rccm.200202-108OC
197. Oury TD, Schaefer LM, Fattman CL, Choi A, Weck KE, Watkins SC. Depletion of pulmonary EC-SOD after exposure to hyperoxia. Am J Physiol Lung Cell Mol Physiol (2002) 283(4):L777-84. doi:10.1152/ajplung.00011.2002
198. Carlsson LM, Jonsson J, Edlund T, Marklund SL. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci U S A (1995) 92(14):6264-8. doi:10.1073/pnas.92.14.6264
199. Auten RL, O'Reilly MA, Oury TD, Nozik-Grayck E, Whorton MH. Transgenic extracellular superoxide dismutase protects postnatal alveolar epithelial proliferation and development during hyperoxia. Am J Physiol Lung Cell Mol Physiol (2006) 290(1):L32-40. doi:10.1152/ajplung.00133.2005
200. Chen S, Birk DE. The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly. FEBS J (2013) 280(10):2120-37. doi:10.1111/febs.12136
201. Godoy-Guzmán C, San Martin S, Pereda J. Proteoglycan and collagen expression during human air conducting system development. Eur J Histochem (2012) 56(3):e29. doi:10.4081/ejh.2012.e29
202. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem (1999) 274(31):21491-4. doi:10.1074/jbc.274.31.21491
203. Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci (2002) 3(4):409-21. doi:10.2174/1389203023380549
204. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem (1988) 263(14):6579-87
205. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem (1989) 264(29):17213-21
206. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG. Human 92-and 72-kilodalton type IV collagenases are elastases. J Biol Chem (1991) 266(12):7870-5
207. Ruiz V, Ordonez RM, Berumen J, Ramirez R, Uhal B, Becerril C, et al. Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol (2003) 285(5):L1026-36. doi:10.1152/ajplung.00183.2003
208. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science (1997) 277(5334):2002-4. doi:10.1126/science.277.5334.2002
209. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev (2000) 14(2):163-76
210. Lukkarinen H, Hogmalm A, Lappalainen U, Bry K. Matrix metalloproteinase-9 deficiency worsens lung injury in a model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol (2009) 41(1):59-68. doi:10.1165/rcmb.2008-0179OC
211. Schulz CG, Sawicki G, Lemke RP, Roeten BM, Schulz R, Cheung PY. MMP-2 and MMP-9 and their tissue inhibitors in the plasma of preterm and term neonates. Pediatr Res (2004) 55(5):794-801. doi:10.1203/01.PDR.0000120683.68630.FB
212. Csiszar K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol (2001) 70:1-32. doi:10.1016/S0079-6603(01)70012-8
213. Kagan HM, Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem (2003) 88(4):660-72. doi:10.1002/jcb.10413
214. Zhan P, Shen XK, Qian Q, Zhu JP, Zhang Y, Xie HY, et al. Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas. Med Oncol (2012) 29(2):648-55. doi:10.1007/s12032-011-9959-z
215. Mäki JM, Rasanen J, Tikkanen H, Sormunen R, Makikallio K, Kivirikko KI, et al. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation (2002) 106(19):2503-9. doi:10.1161/01.CIR.0000038109.84500.1E
216. Hornstra IK, Birge S, Starcher B, Bailey AJ, Mecham RP, Shapiro SD. Lysyl oxidase is required for vascular and diaphragmatic development in mice. J Biol Chem (2003) 278(16):14387-93. doi:10.1074/jbc.M210144200
217. Giampuzzi M, Botti G, Di Duca M, Arata L, Ghiggeri G, Gusmano R, et al. Lysyl oxidase activates the transcription activity of human collagene III promoter. Possible involvement of Ku antigen. J Biol Chem (2000) 275(46):36341-9. doi:10.1074/jbc.M003362200
218. Herranz N, Dave N, Millanes-Romero A, Morey L, Diaz VM, Lorenz-Fonfria V, et al. Lysyl oxidase-like 2 deaminates lysine 4 in histone H3. Mol Cell (2012) 46(3):369-76. doi:10.1016/j.molcel.2012.03.002
219. Lugassy J, Zaffryar-Eilot S, Soueid S, Mordoviz A, Smith V, Kessler O, et al. The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation. J Biol Chem (2012) 287(5):3541-9. doi:10.1074/jbc.M111.261016
220. Myllyla R, Wang C, Heikkinen J, Juffer A, Lampela O, Risteli M, et al. Expanding the lysyl hydroxylase toolbox: new insights into the localization and activities of lysyl hydroxylase 3 (LH3). J Cell Physiol (2007) 212(2):323-9. doi:10.1002/jcp.21036
221. Rautavuoma K, Takaluoma K, Sormunen R, Myllyharju J, Kivirikko KI, Soininen R. Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice. Proc Natl Acad Sci U S A (2004) 101(39):14120-5. doi:10.1073/pnas.0404966101
222. Takaluoma K, Hyry M, Lantto J, Sormunen R, Bank RA, Kivirikko KI, et al. Tissue-specific changes in the hydroxylysine content and cross-links of collagens and alterations in fibril morphology in lysyl hydroxylase 1 knock-out mice. J Biol Chem (2007) 282(9):6588-96. doi:10.1074/jbc.M608830200
223. Beninati S, Bergamini CM, Piacentini M. An overview of the first 50 years of transglutaminase research. Amino Acids (2009) 36(4):591-8. doi:10.1007/s00726-008-0211-x
224. Iismaa SE, Mearns BM, Lorand L, Graham RM. Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev (2009) 89(3):991-1023. doi:10.1152/physrev.00044.2008
225. Akimov SS, Krylov D, Fleischman LF, Belkin AM. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol (2000) 148(4):825-38. doi:10.1083/jcb.148.4.825
226. Olsen KC, Epa AP, Kulkarni AA, Kottmann RM, McCarthy CE, Johnson GV, et al. Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules. Am J Respir Cell Mol Biol (2014) 50(4):737-47. doi:10.1165/rcmb.2013-0092OC
227. Griffin M, Smith LL, Wynne J. Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat. Br J Exp Pathol (1979) 60(6):653-61
228. Luciani A, Villella VR, Esposito S, Brunetti-Pierri N, Medina DL, Settembre C, et al. Cystic fibrosis: a disorder with defective autophagy. Autophagy (2011) 7(1):104-6. doi:10.4161/auto.7.1.13987
229. Maiuri L, Luciani A, Giardino I, Raia V, Villella VR, D'Apolito M, et al. Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation. J Immunol (2008) 180(11):7697-705. doi:10.4049/jimmunol.180.11.7697
230. Penumatsa KC, Fanburg BL. Transglutaminase 2-mediated serotonylation in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2014) 306(4):L309-15. doi:10.1152/ajplung.00321.2013
231. Piacentini M, Rodolfo C, Farrace MG, Autuori F. "Tissue" transglutaminase in animal development. Int J Dev Biol (2000) 44(6):655-62. doi:10.1007/bfb0102308
232. Schittny JC, Paulsson M, Vallan C, Burri PH, Kedei N, Aeschlimann D. Protein cross-linking mediated by tissue transglutaminase correlates with the maturation of extracellular matrices during lung development. Am J Respir Cell Mol Biol (1997) 17(3):334-43. doi:10.1165/ajrcmb.17.3.2737
233. Kojima S, Nara K, Rifkin DB. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol (1993) 121(2):439-48. doi:10.1083/jcb.121.2.439
234. Nanda N, Iismaa SE, Owens WA, Husain A, Mackay F, Graham RM. Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem (2001) 276(23):20673-8. doi:10.1074/jbc.M010846200
235. Rawlins EL, Perl AK. The a"MAZE"ing world of lung-specific transgenic mice. Am J Respir Cell Mol Biol (2012) 46(3):269-82. doi:10.1165/rcmb.2011-0372PS
236. Shojaie S, Ermini L, Ackerley C, Wang J, Chin S, Yeganeh B, et al. Acellular lung scaffolds direct differentiation of endoderm to functional airway epithelial cells: requirement of matrix-bound HS proteoglycans. Stem Cell Reports (2015) 4(3):419-30. doi:10.1016/j.stemcr.2015.01.004